Market Overview

Oppenheimer Reiterates Outperform and PT of $21 on MedAssets


Oppenheimer reiterated its Outperform rating on MedAssets (NASDAQ: MDAS). At the same time, Oppenheimer left its price target on the company's stock unchanged at $21. In today's trading, MedAssets added 0.04% to its value to trade around $13.20.

Posted-In: medassets OppenheimerReiteration Analyst Ratings


Related Articles (MDAS)

View Comments and Join the Discussion!

Get Benzinga's Newsletters